Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.85 EUR | +0.54% | +0.54% | +0.54% |
2023 | Pangaea Oncology, S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | Pangaea Oncology, S.A. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
Sales 2024 * | 13.8M 14.95M 20.44M | Sales 2025 * | 14.8M 16.03M 21.93M | Capitalization | 54.18M 58.7M 80.26M |
---|---|---|---|---|---|
Net income 2024 * | -1M -1.08M -1.48M | Net income 2025 * | - 0 0 | EV / Sales 2024 * | 4.32 x |
Net Debt 2024 * | 5.5M 5.96M 8.15M | Net Debt 2025 * | 6.8M 7.37M 10.07M | EV / Sales 2025 * | 4.12 x |
P/E ratio 2024 * |
-36.8
x | P/E ratio 2025 * |
-92
x | Employees | 58 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 21.08% |
1 day | +0.54% | ||
1 week | +0.54% | ||
Current month | +5.71% | ||
1 month | +6.94% | ||
3 months | +1.65% | ||
6 months | -0.54% | ||
Current year | +0.54% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 06-12-31 | |
Founder | - | 06-12-31 | |
Founder | - | 06-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | - | 06-12-31 | |
Founder | - | 06-12-31 | |
Founder | - | 06-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-22 | 1.85 | +0.54% | 1 819 |
24-05-21 | 1.84 | 0.00% | 0 |
24-05-20 | 1.84 | 0.00% | 0 |
24-05-17 | 1.84 | 0.00% | 0 |
24-05-16 | 1.84 | 0.00% | 0 |
Delayed Quote BME, May 22, 2024 at 06:00 am
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+0.54% | 58.83M | |
+44.48% | 55.07B | |
-0.86% | 41.79B | |
+44.13% | 40.22B | |
-7.59% | 28.17B | |
+12.30% | 26.28B | |
-21.83% | 18.93B | |
+7.15% | 13.03B | |
+29.40% | 12.26B | |
+25.15% | 12.21B |
- Stock Market
- Equities
- PANG Stock